In 2024, the global oral proteins and peptides market was valued at USD 1.8 Billion. Forecasts by IMARC Group indicate the market will expand to USD 3.4 Billion by 2033, with a steady CAGR of 7.13% from 2025-2033. North America holds a commanding market share of 97.8%. This growth is fueled by innovations in drug delivery technologies and a rising demand for non-invasive treatment opt... https://www.imarcgroup.com/oral-proteins-peptides-market